Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study

Mirza Sharifuzzaman, Ajit Paul, Md Akteruzzaman, SN Haider Bhuiyan, Rezaul Haider, Shoma Sharker, Dahlia Sultana, Khondoker Alam, Sikandar Abu Zafar, Md Kashem, Md Abu Zahid, AFM Nazmul Islam, Md Zainal Abedin, Fouzia Anar, Md Farucul Hasan, Shahjada Selim, Sunjida Islam, Afsar Ahammed, Mobarak Hosen, Nazmul Qureshi, Mohammad Hossain, Aysha Begum, Farhana Afrooz, ASM Musa Kobir, Farhana Akter, Sadia Mustafa, Md Motiur Rahman, M Saifuddin

Open source

DOI: 10.2147/dmso.s542107
Published: 2025-12
Container: Diabetes, Metabolic Syndrome and Obesity
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/dmso.s542107,
  title = {Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study},
  author = {Mirza Sharifuzzaman and Ajit Paul and Md Akteruzzaman and SN Haider Bhuiyan and Rezaul Haider and Shoma Sharker and Dahlia Sultana and Khondoker Alam and Sikandar Abu Zafar and Md Kashem and Md Abu Zahid and AFM Nazmul Islam and Md Zainal Abedin and Fouzia Anar and Md Farucul Hasan and Shahjada Selim and Sunjida Islam and Afsar Ahammed and Mobarak Hosen and Nazmul Qureshi and Mohammad Hossain and Aysha Begum and Farhana Afrooz and ASM Musa Kobir and Farhana Akter and Sadia Mustafa and Md Motiur Rahman and M Saifuddin},
  year = {2025},
  journal = {Diabetes, Metabolic Syndrome and Obesity},
  doi = {10.2147/dmso.s542107},
  url = {https://doi.org/10.2147/dmso.s542107}
}

RIS

TY  - JOUR
TI  - Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study
AU  - Mirza Sharifuzzaman
AU  - Ajit Paul
AU  - Md Akteruzzaman
AU  - SN Haider Bhuiyan
AU  - Rezaul Haider
AU  - Shoma Sharker
AU  - Dahlia Sultana
AU  - Khondoker Alam
AU  - Sikandar Abu Zafar
AU  - Md Kashem
AU  - Md Abu Zahid
AU  - AFM Nazmul Islam
AU  - Md Zainal Abedin
AU  - Fouzia Anar
AU  - Md Farucul Hasan
AU  - Shahjada Selim
AU  - Sunjida Islam
AU  - Afsar Ahammed
AU  - Mobarak Hosen
AU  - Nazmul Qureshi
AU  - Mohammad Hossain
AU  - Aysha Begum
AU  - Farhana Afrooz
AU  - ASM Musa Kobir
AU  - Farhana Akter
AU  - Sadia Mustafa
AU  - Md Motiur Rahman
AU  - M Saifuddin
PY  - 2025
JO  - Diabetes, Metabolic Syndrome and Obesity
DO  - 10.2147/dmso.s542107
UR  - https://doi.org/10.2147/dmso.s542107
ER  -

APA

Sharifuzzaman, M., Paul, A., Akteruzzaman, M., Bhuiyan, S. H., Haider, R., Sharker, S., Sultana, D., Alam, K., Zafar, S. A., Kashem, M., Zahid, M. A., Islam, A. N., Abedin, M. Z., Anar, F., Hasan, M. F., Selim, S., Islam, S., Ahammed, A., Hosen, M., Qureshi, N., Hossain, M., Begum, A., Afrooz, F., Kobir, A. M., Akter, F., Mustafa, S., Rahman, M. M., & Saifuddin, M. (2025). Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study. Diabetes, Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s542107

Source records

crossref · retrieved 2026-09-27T07:26:18.317Z